Dr. William C. Reha discusses scope of practice issues in urology

"A lot of ancillary providers want more privileges that the physician has, and we have to be the guardians and the reason we're doing this is to protect our patients so that they get the best care available to them," says William C. Reha, MD, MBA.

Related Videos

Related Content

Advertisement

May 6th 2025

AUA Advocacy Summit: Medicare payment reform among top priorities

Jennifer Miles-Thomas, MD, URPS, MBA Benjamin P. Saylor

Jennifer Miles-Thomas, MD, URPS, MBA, discusses the AUA's legislative priorities along with issues in medicine related to artificial intelligence.

May 4th 2025

Health policy expert highlights the importance of state-level urology advocacy

Benjamin P. Saylor

"Developing a relationship with your legislator is just as important at the state level as it is at the federal level," says Hans Arora, MD, PhD.

April 22nd 2025

Biomarkers in urology: Policy and legislative advances

Ron Lanton, Esq

"The AACU has been discussing the evolution of state policy to ensure that biomarker testing, including PSA screening, is covered by payers," writes Ron Lanton, Esq.

March 12th 2025

House passes bill that includes 57% budget cut to medical research programs

Hannah Clarke

This bill would cut funds for research projects in disease states such as prostate cancer, bladder cancer, kidney cancer, and interstitial cystitis.

March 7th 2025

Data refute concerns about telehealth as Congress weighs legislation

Hannah Clarke

“Five years after telehealth suddenly became a routine part of care for most Americans, we show that it has not led to runaway utilization or spending. This kind of in-depth analysis can inform its future," says Chad Ellimoottil, MD, MS.

January 17th 2025

Enzalutamide included in next round of Medicare drug price negotiations

Hannah Clarke

The 15 drugs identified in this round of negotiations add to the 10 selected in the first round of negotiations that took place in 2023 and 2024.

Related Content

Advertisement

May 6th 2025

AUA Advocacy Summit: Medicare payment reform among top priorities

Jennifer Miles-Thomas, MD, URPS, MBA Benjamin P. Saylor

Jennifer Miles-Thomas, MD, URPS, MBA, discusses the AUA's legislative priorities along with issues in medicine related to artificial intelligence.

May 4th 2025

Health policy expert highlights the importance of state-level urology advocacy

Benjamin P. Saylor

"Developing a relationship with your legislator is just as important at the state level as it is at the federal level," says Hans Arora, MD, PhD.

April 22nd 2025

Biomarkers in urology: Policy and legislative advances

Ron Lanton, Esq

"The AACU has been discussing the evolution of state policy to ensure that biomarker testing, including PSA screening, is covered by payers," writes Ron Lanton, Esq.

March 12th 2025

House passes bill that includes 57% budget cut to medical research programs

Hannah Clarke

This bill would cut funds for research projects in disease states such as prostate cancer, bladder cancer, kidney cancer, and interstitial cystitis.

March 7th 2025

Data refute concerns about telehealth as Congress weighs legislation

Hannah Clarke

“Five years after telehealth suddenly became a routine part of care for most Americans, we show that it has not led to runaway utilization or spending. This kind of in-depth analysis can inform its future," says Chad Ellimoottil, MD, MS.

January 17th 2025

Enzalutamide included in next round of Medicare drug price negotiations

Hannah Clarke

The 15 drugs identified in this round of negotiations add to the 10 selected in the first round of negotiations that took place in 2023 and 2024.